Jonathan Melnick

Senior Director, Technology Innovation at 4D Molecular Therapeutics LLC - Oakland, CA, US

Jonathan Melnick's Colleagues at 4D Molecular Therapeutics LLC
Reese Isaacson

Associate Director, Corporate Strategy

Contact Reese Isaacson

Catherine Campbell

Senior Director Regulatory Affairs

Contact Catherine Campbell

Susan Limb

Vice President, Medical Director, Lung Program

Contact Susan Limb

Ken Glasscock

Senior Director, Scientific Communications

Contact Ken Glasscock

Ken Imamura

Director, Clinical Operations

Contact Ken Imamura

Michael Zanoni

Vice President, Investor Relations & Corporate Affairs

Contact Michael Zanoni

View All Jonathan Melnick's Colleagues
Jonathan Melnick's Contact Details
HQ
510-505-2680
Location
Walnut Creek,California,United States
Company
4D Molecular Therapeutics LLC
Jonathan Melnick's Company Details
4D Molecular Therapeutics LLC logo, 4D Molecular Therapeutics LLC contact details

4D Molecular Therapeutics LLC

Oakland, CA, US • 100 - 249 Employees
BioTech/Drugs

We are 4DMT! Our mission is to boldly innovate to unlock the full potential of gene therapy for countless patients. 4DMT is a leader in next-generation AAV gene therapy discovery through its proprietary therapeutic vector evolution platform that empowers us to invent optimized and proprietary AAV vectors, each specifically tailored for the treatment of a rare disease with a high unmet medical need. We strive to become the most impactful company in the gene therapy industry.We are pioneering the development of precision gene therapies based on our proprietary AAV vectors. Our transformative discovery platform, Therapeutic Vector Evolution, enables our "disease first" approach to product discovery, design and development. We use our platform to discover custom and proprietary AAVs designed for specific tissues and diseases, which we believe will allow us to overcome known limitations of conventional AAV vectors and potentially address a broad range of both rare and large market diseases. Based on our Target Vector Profile for a disease, we select customized capsids in non-human primates from an estimated over one billion vector capsid sequences in our 37 proprietary and diverse AAV vector libraries as of August 1, 2019. We are developing a diverse pipeline in a broad range of therapeutic areas of wholly owned and partnered programs.We seek the best in the industry who identify with our mission and innovative results-driven approach. Our 4 Guiding Principles drive our actions, and they are: Dare to Cure (create big dreams for patients, innovate and take calculated risks to achieve them); Break Boundaries (questioning and moving beyond the status quo); Beyond Yourself (we are patient and team focused); and Prepare & Executive Relentlessly (be proactive and start with the end in mind).

Gene Therapy Adeno-Associated Virus B2B Biotech SaaS Commercial Physical Research Biotechnology Biotech Pharmaceuticals
Details about 4D Molecular Therapeutics LLC
Frequently Asked Questions about Jonathan Melnick
Jonathan Melnick currently works for 4D Molecular Therapeutics.
Jonathan Melnick's role at 4D Molecular Therapeutics is Senior Director, Technology Innovation.
Jonathan Melnick's email address is ***@4dmt.com. To view Jonathan Melnick's full email address, please signup to ConnectPlex.
Jonathan Melnick works in the Research industry.
Jonathan Melnick's colleagues at 4D Molecular Therapeutics LLC are Reese Isaacson, Catherine Campbell, Susan Limb, Kim Maplestone, Ken Glasscock, Ken Imamura, Michael Zanoni and others.
Jonathan Melnick's phone number is 510-505-2680
See more information about Jonathan Melnick